GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia

被引：0
作者：
Xinhua Xiao
Peihong Wang
Weina Zhang
Jiayi Wang
Mansi Cai
Hua Jiang
Yingli Wu
Huizhuang Shan
机构：
[1] Guangzhou Medical University,Department of Hematology and Oncology, Guangzhou Women and Children’s Medical Center
[2] Southern Medical University,Department of Clinical Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences)
[3] Guangzhou First People’s Hospital,Department of Hematology
[4] South China University of Technology,Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Basic Medicine, Chemical Biology Division of Shanghai Universities E
[5] Shanghai Jiao Tong University School of Medicine,Institutes, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Research Units of Stress and Tumor (2019RU043)
[6] Chinese Academy of Medical Sciences,undefined
来源：
Cancer Cell International | / 23卷
关键词：
Acute myeloid leukemia; FLT3-ITD; GNF-7; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 161 条
  • [1] Daver N(2019)Targeting FLT3 mutations in AML: review of current knowledge and evidence Leukemia 33 299-312
  • [2] Schlenk RF(2012)Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis J Clin Oncol 30 735-741
  • [3] Russell NH(2007)FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia Blood 110 1262-1270
  • [4] Levis MJ(2013)FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia Leukemia 27 260-268
  • [5] Brunet S(2011)Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications J Hematol Oncol 4 13-273
  • [6] Labopin M(2005)AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations Blood 106 265-670
  • [7] Esteve J(2021)Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia Haematologica 106 664-263
  • [8] Cornelissen J(2012)Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia Nature 485 260-58
  • [9] Socie G(2017)Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis Blood 130 48-55
  • [10] Iori AP(2018)FLT3 inhibitors in acute myeloid leukemia J Hematol Oncol 11 133-5448
12345678910